205 related articles for article (PubMed ID: 16288477)
41. Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon.
Venables JP; Bourgeois CF; Dalgliesh C; Kister L; Stevenin J; Elliott DJ
Hum Mol Genet; 2005 Aug; 14(16):2289-303. PubMed ID: 16000324
[TBL] [Abstract][Full Text] [Related]
42. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.
Yang Y; Swaminathan S; Martin BK; Sharan SK
Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465
[TBL] [Abstract][Full Text] [Related]
43. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
Chew SL; Liu HX; Mayeda A; Krainer AR
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
[TBL] [Abstract][Full Text] [Related]
44. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
45. Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes.
Meng F; Zolova O; Kokorina NA; Dobretsova A; Wight PA
J Neurosci Res; 2005 Nov; 82(3):346-56. PubMed ID: 16155935
[TBL] [Abstract][Full Text] [Related]
46. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
47. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
[TBL] [Abstract][Full Text] [Related]
48. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
49. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
50. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
Li X; Shambaugh ME; Rottman FM; Bokar JA
RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
52. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
[TBL] [Abstract][Full Text] [Related]
53. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
54. A PLP splicing abnormality is associated with an unusual presentation of PMD.
Hobson GM; Huang Z; Sperle K; Stabley DL; Marks HG; Cambi F
Ann Neurol; 2002 Oct; 52(4):477-88. PubMed ID: 12325077
[TBL] [Abstract][Full Text] [Related]
55. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
56. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
57. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells.
Tardos JG; Eisenreich A; Deikus G; Bechhofer DH; Chandradas S; Zafar U; Rauch U; Bogdanov VY
J Thromb Haemost; 2008 May; 6(5):877-84. PubMed ID: 18315555
[TBL] [Abstract][Full Text] [Related]
58. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes.
Werner H; Dimou L; Klugmann M; Pfeiffer S; Nave KA
Mol Cell Neurosci; 2001 Dec; 18(6):593-605. PubMed ID: 11749036
[TBL] [Abstract][Full Text] [Related]
59. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
60. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
